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HypertensionAbstract Background: Hypertension has been shown to carry an increased risk not only for cere-
brovascular stroke but also for cognitive impairment and dementia. Ambulatory blood pressure
monitoring (ABPM) is a good predictor of cardiac, renal, and cerebral disease in middle-aged
and older people with hypertension.
Patients and methods: The study included 77 elderly (mean age: 69 years) subjects. Based on the
history of hypertension, ofﬁce blood pressure, and ABPM, patients were classiﬁed into 2 groups,
Group I: 22 persons as a control group and Group II: 55 hypertensive patients. The hypertensive
group was further sub classiﬁed by using data of ABPM into dippers and non-dippers. Both groups
were subjected to clinical examination, laboratory analysis, ABPM, Transthoracic Echocardio-
graphic Examination, brain magnetic resonance imaging (MRI) and mini-mental state examination
(MMSE) of their cognitive function.
Results: There was a statistically signiﬁcant positive correlation between the cerebral MRI score
and each of the average 24-h systolic, diastolic and mean arterial blood pressure, average morning
systolic, diastolic, mean arterial blood pressure, average night systolic, diastolic and mean arterial
blood pressure. There was also a statistically signiﬁcant negative correlation between the MMSE
8 K.S. Mahmoud et al.score and the previous parameters. A non signiﬁcant correlation was noted between the cerebral
MRI score and the ofﬁce systolic and diastolic blood pressure in hypertensive group.
Conclusion: The study demonstrated that hypertensive patients diagnosed by ABPM have signiﬁ-
cantly more impaired cognitive function than control subjects as proved by the mini-mental state
examination and brain MRI score of white matter disease.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
High blood pressure (BP) is a risk factor for cerebrovascular dis-
ease, including stroke. Little is known about the importance of
BP on the progression of microvascular disease of the brain,
which has been associated with functional decline in mobility
and cognition in older people.1 An important advantage of
ambulatory blood pressure (ABPM) measurement over ofﬁce
BP assessment, is its enhanced reproducibility. Numerous stud-
ies have demonstrated that ambulatory BP is a better predictor
of cardiac, renal, and cerebral disease in middle-aged and older
people with hypertension.2 Small vessel disease of the brain may
present as white matter hyperintensities (WMHs) and these are
commonly present in the magnetic resonance images (MRI) of
older persons with hypertension and other vascular disease risk
factors.3 These WMHs are clinically relevant in older people
because they are associated with functional deterioration of
mobility, cognition4 and stroke.5 They have been proposed as
an intermediate marker in the research setting.6
2. The aim of the study
The aim of this study was to test the correlation of the 24-h
ABPM data to the cognitive function of elderly hypertensive
patients even if their ofﬁce BP is normal.
3. Patients and methods
The study included 77 elderly patients (mean age: 69 years).
Hypertension is considered present if the average clinic
recorded BP reading exceeded 140/90 mmHg and/or if average
24-h BP reading exceeded 130/80 mmHg.7,8 Based on history
of hypertension, ofﬁce blood pressure (average of 3 readings)
and ABPM, patients were classiﬁed into two groups:
 Group I: 22 persons as a control group (no history of hyper-
tension, and no ofﬁce or ABPM evidence of hypertension).
 Group II: 55 hypertensive patients by history, ofﬁce BP or
ABPM.
The hypertensive group was further sub-divided according
to the data of ABPM into dipper hypertensive (n= 18) and
non-dipper hypertensive (n= 37) patients. Dipper means that
there is drop in nocturnal BP than day blood pressure by 10–
20% followed by an increase early in the morning.
Exclusion criteria: (1) Patients with underlying neurological
disorders that would impair mobility or cognitive function. (2)
Patients with severe or unstable cardiovascular disorders (e.g.,
myocardial infarction in the last 6 months, decompensated
heart failure, stroke). (3) Diabetic patients. Diabetes mellitus
was considered to be present if the patient was on anti diabetic
medication or by abnormal HbA1C.9 (4) Renal impairmentpatients. The estimated Glomerular Filtration Rate (eGFR)
was calculated using Cockcroft-Gault formula.10
eGFR ¼ ½140 age in years  weight ðkgÞ
72 serumcreatinine level ðmg=dLÞ  0:85
The studied groups were subjected to:
(1) Personal history, history of previous acute coronary syn-
drome (ACS), interventions, diabetes mellitus and esti-
mation of traditional risk factors as cigarette smoking
and dyslipidemia.
(2) Clinical Examination, which included BP measurement.
BP was measured in the supine position after 5 min of
rest, using a large cuff when necessary, with a standard
mercury sphygmomanometer.
(3) Laboratory analysis, which included random and fasting
blood sugar, renal function tests and lipid proﬁle after
fasting for at least 12 h.
(4) Transthoracic Echocardiography: Two-dimensional, M-
mode, Doppler and color-Doppler echocardiographic
examinations were performed using GE Vivid III expert
machine (GE Medical Systems, Waukesha, WI),
equipped by Tissue-Doppler mode, with 2.5 MHz phase
array transducer. M-mode, color ﬂow mapping, pulsed
and continuous wave Doppler recordings were obtained
for each subject. Measurements of LV end-diastolic
(EDD) and end-systolic diameters and of the interven-
tricular septal (IVS) and posterior wall (PWT) thick-
nesses in diastole were obtained from a standard
parasternal long-axis view according to the recommen-
dations of the American Echocardiography society.11
LV mass was calculated according to the formula as cor-
rected by Devereux and Reichek.12,13
(5) 24-h ambulatory BP monitoring (ABPM): Subjects were
ﬁtted with a BP monitor (Contec ABPM50, Germany).
Patients were monitored for 24 h, with readings being
obtained every 30 min during day-time (8 AM–12 PM)
and at 60-min intervals during night-time (12 PM–8
AM).
(6) Assessment of cognitive function: The mini-mental state
examination (MMSE) or Folstein test is a brief 30-point
questionnaire test that is used to screen for cognitive
impairment.14 It is used to estimate the severity of cog-
nitive impairment. The questions of the MMSE include
asking about Orientation (Time, date, day, month,
year), Registration (Name three objects only once),
Attention and calculation (Ask the patient to subtract
7 from 100 and then 7 from the result four more times),
Recall (Ask the patient to repeat the names of the three
objects learnt in the registration test) and Language
(Score 1 point for each of two simple objects named).
The scores from each step are added to give the total
score. A score greater than or equal to 25 points (out
Table 2 Demographic description of the patients.
Control Hypertensive P-value
Age 68.36 ± 2.66 69.09 ± 3.58 0.393
Sex: n (%)
Male: 13 (59.1%) 28 (50.9%) 0.516
Female: 9 (40.9%) 27 (49.1%)
Smoking: n (%)
Smoker: 11 (50%) 29 (52.7%) 0.829
Non smoker: 11 (50%) 26 (47.3%)
Dyslipidemia: n (%)
Dyslipidemic: 4 (18.2%) 16 (29.1%) 0.324
Non dyslipidemic: 18 (81.8%) 39 (70.9%)
Table 3 Comparison between hypertensive and control
groups regarding brain MRI & MMSE scores.
Control Hypertensive P-value
MRI score 1.54 ± 1.05 16.12 ± 9.58 <0.001
MMSE score 26.27 ± 2.18 14.50 ± 5.54 <0.001
Table 4 Comparison between dipper and non dipper hyper-






MRI score 15.86 ± 9.49 16.66 ± 10.01 0.735
MMSE score 14.27 ± 5.27 14.62 ± 5.73 0.807
Table 1 Description of the modiﬁed Scheltens MRI score for cerebral WMH.
Cerebral hemisphere
PVCs (0–6) x3 (frontal, occipital & lateral) DWMHCs (0–24) x4 (frontal,
parietal, temporal, occipital
lobes)
Basal ganglia Changes x5 (0–30)
(caudate, Putamen, GP, Thalamus
& IC)
0 NAD 0 NAD 0 NAD
1 65 mm 1 <3 mm in 65 1 <3 mm in 65
2 5< x <10 mm 2 <3 mm in P6 2 <3 mm in P6
P10 mm is not considered PVCs 3 4–10 mm in 65 3 4–10 mm in 65
4 4–10 mm in P6 4 4–10 mm in P6
*ifP10 mm, Considered as 2 and the excess of the lesion is dealt
with as DWMHCs in its particular lobe
5 >11 mm in >1 5 >11 mm in >1
6 Conﬂuent 6 Conﬂuent
NAD: No abnormality detected.
Values of ambulatory blood pressure monitoring 9of 30) is normal. A score of (69 points) indicates severe
cognitive impairment. A score of (10–20 points) indi-
cates moderate cognitive impairment and a score of
(21–24 points) indicates mild cognitive impairment.
(7) Brain MRI and quantitative assessment of white matter
hyperintensity (WMH): Patients had a customized sim-
ple brain MRI study that is composed of standard axial
T1 weighted, axial T2 weighted and axial FLAIR
sequences. The MRI study was done on a 0.2T GE
Signa Excite machine (GE Medical Systems, Waukesha,
WI). The evaluation of the MRI was to exclude other
causes of cognitive impairment, e.g. Alzheimer disease
and to score the white matter hyperintensities. MRI
was also needed to conﬁrm the results of the MMSE
score. The deep white matter hyperintensities were eval-
uated and scored according to the modiﬁed Scheltens
score.15 The modiﬁed Scheltens score is represented in
the following table (Table 1).
4. Statistical analysis
Statistical analysis was carried out using SPSS version 16 for
windows (SPSS Inc., Cary, NC). The analysis of the difference
of nominal data, e.g. gender, between groups and subgroups
was carried out using the Chi Square test. Statistical signiﬁ-
cance of differences in continuous variables was assessed using
Student’s t test. Bivariate Pearson’s correlations were carried
out between each of the ofﬁce BP measurements and the 24-
h ABPM variables and the MMSE and the MRI score. A lin-
ear regression analysis was run to ﬁnd the factors with stronger
impact on the cognitive function. Signiﬁcance level for the used
tests is P= 0.05.5. Results
There was no statistically signiﬁcant difference between the
control and hypertensive groups as regards age, sex, smoking,
and dyslipidemia (Table 2).
As regards the Echocardiographic data there was a statisti-
cally signiﬁcant difference between hypertensive and control
groups regarding LVID, IVSD, PWD and LVM (P< 0.05),
however there was no statistically signiﬁcant difference regard-
ing LV systolic function (P= 0.108).Regarding ambulatory blood pressure monitoring data
there was no statistically signiﬁcant difference between hyper-
tensive subgroups (dipper and non-dipper) regarding data of
average 24 h and morning ABPM (P> 0.1). However, there
was a signiﬁcant difference between hypertensive subgroups
(dipper and non-dipper) regarding data of average night
ABPM (P< 0.003).
There was a statistically signiﬁcant difference in the MRI
and MMSE scores between hypertensive and control groups
(Table 3).
There was no signiﬁcant difference between the hyperten-
sive subgroups dipper and non-dipper regarding the MRI or
the MMSE scores (Table 4).
Table 5 Correlation between brain MRI score and blood
pressure in hypertensive patients.
Hypertensive
R P
MRI score & oﬃce systolic 0.180 0.729
MRI score & oﬃce diastolic 0.093 0.502
MRI score & average 24 h SBP 0.905 <0.001
MRI score & average 24 h DBP 0.759 <0.001
MRI score & average 24 h MAP 0.772 <0.001
MRI score & average morning SBP 0.903 <0.001
MRI score & average morning DBP 0.903 <0.001
MRI score & average morning MAP 0.777 <0.001
MRI score & average night SBP 0.495 <0.001
MRI score & average night DBP 0.706 <0.001
MRI score & average night MAP 0.640 <0.001
Table 6 Correlation between the MMSE score and blood
pressure in hypertensive patients.
Hypertensive
R P
MMSE score & oﬃce systolic 0.185 0.177
MMSE score & oﬃce diastolic 0.115 0.402
MMSE score & average 24 h SBP 0.816 <0.001
MMSE score & average 24 h DBP 0.683 <0.001
MMSE score & average 24 h MAP 0.684 <0.001
MMSE score & average morning SBP 0.813 <0.001
MMSE score & average morning DBP 0.732 <0.001
MMSE score & average morning MAP 0.701 <0.001
MMSE score & average night SBP 0.442 <0.001
MMSE score & average night DBP 0.656 <0.001
MMSE score & average night MAP 0.564 <0.001
Figure 2 Correlation between the MMSE score and MRI score.
10 K.S. Mahmoud et al.There was no signiﬁcant correlation between the MRI score
and ofﬁce BP measurements. On the other hand, there was a
statistically signiﬁcant positive correlation between MRI score
and each of the average 24-h systolic, diastolic and mean arte-Figure 1 Correlation between the MRI & Mrial blood pressure, average morning systolic, diastolic, mean
arterial blood pressure, average night systolic, diastolic and
mean arterial blood pressure as shown in table 5.
Similarly, there was no signiﬁcant correlation between the
MMSE score and ofﬁce BP measurements, while there was a
statistically signiﬁcant negative correlation between the
MMSE score and each of the average 24-h systolic, diastolic
and mean arterial blood pressure, average morning systolic,
diastolic, mean arterial blood pressure, average night systolic,
diastolic and mean arterial blood pressure as shown in table 6.
Multivariate regression analysis revealed that morning sys-
tolic ABPM was a signiﬁcantly higher predictor for MRI
changes (R= 0.911, R2 = 0.830, P< 0.001). Similarly, the
morning systolic ABPM was also a signiﬁcantly higher predic-
tor for MMSE score (R= 0.868, R2 = 0.754, P< 0.001).
The duration of hypertension revealed a statistically signif-
icant positive correlation to the MRI score and a statistically
signiﬁcant negative correlation to the MMSE score (Fig. 1).
When comparing the MRI and MMSE scores, a signiﬁcant
negative correlation was found between them (R= 0.827,
P< 0.001). (Fig. 2)MSE scores and duration of hypertension.
Values of ambulatory blood pressure monitoring 116. Discussion
It is well known that hypertension causes damage to many of
the body’s organs, including the heart, kidneys, eyes, and
brain, and it is a major risk factor for coronary heart disease
and stroke. However, the impact of hypertension on the brain
prior to stroke is presently under recognized. Even in otherwise
healthy people, hypertension can lead to mild to moderate
alterations in the brain’s structure and function, including its
ability to efﬁciently process information (known as cognitive
function). These early hypertension related changes in the
brain can be detected by sophisticated brain scans and by neu-
ropsychological assessment of cognitive abilities.16
Silent cerebral white matter lesions (WMLs) are a common
ﬁnding on brain magnetic resonance imaging (MRI) in the
elderly. However, in patients with hypertension, WMLs tend
to occur earlier in life and appear to be more severe. There is
evidence that supports the idea that WMLs in asymptomatic
hypertensive patients should be considered a silent early mar-
ker of brain damage.17
The study included 77 individuals with no signiﬁcant differ-
ences regarding age, sex and risk factors (smoking anddyslipide-
mia). We aimed to avoid any bias induced by these risk factors
and this comes in agreement with de Groot et al.18 and Sacco
RL et al.,19 who suggested that age, smoking and dyslipidemia
were risk factors for the development of cognitive impairment.
In the hypertensive group,WMLs were increased, which was
observed by theMRI score and theMMSE score was decreased
compared to the control group. These ﬁndings were consistent
with the results of William White et al., and Yusuke et al.20,21
It is well known that pressures measured in the ofﬁce or clinic
may not be representative of the patient’s blood pressure
throughout the day.22 In this study, it was demonstrated that
the ABPM correlated more with cognitive impairment than
ofﬁce blood pressure. In disagreement with this, Shari and
Christiane23,24 concluded that systolic hypertension measured
in ofﬁce was related to a higher risk of impaired cognitive func-
tion.However, Puisieux25 suggested that this relationship is only
evident when uncontrolled hypertension is conﬁrmed by
(ABPM) which was in agreement with our results.
Our study demonstrated a signiﬁcant positive correlation
between the duration of hypertension and the MRI changes
as well as a signiﬁcant negative correlation between the dura-
tion of hypertension and the MMSE score. This is consistent
with the results of Shu-jian and Willum-Hansen.26,27
The averagemorning systolic blood pressure and average 24-
h systolic blood pressure had the strongest impact on the cere-
bral MRI score and the MMSE score. This ﬁnding could have
several explanations. It could denote that the higher stresses of
morning life cause the systolic blood pressure to exert a higher
damaging effect on the CNS. Another explanation could be that
the circadian rhythm of the corticosteroids assists the damaging
effect of systolic blood pressure upon the CNS during day time
and reduce it by night. Many studies agreed with ours regarding
the effect of average 24-h and average daytime systolic blood
pressure to the cognitive decline and MRI changes.28,29 Nagai
M et al., however disagreed in that the sleeping systolic BP
had a stronger impact upon the cognitive ability, although aver-
age overall and average awake systolic BP were also strongly
correlated to cognitive function.30 To the authors’ best knowl-
edge, few researchers have found a strong correlation betweenthe cognitive impairment and the diastolic blood pressure at
any phase of the 24-h ABPM.31,32
Van Boxtel et al.,28 demonstrated that non dipping diurnal
blood pressure variation is associated with target organ dam-
age of the brain. However in our study, similar to Grandi
and Cesare,33,34 we did not ﬁnd any signiﬁcant difference
between dipper and non dipper regarding MRI changes, cogni-
tive impairment or echocardiographic ﬁndings.
In a sample of treated dipper and non-dipper essential hyper-
tensive patients with different clinic BP controls, the present
study showed that a reduced nocturnal fall in BP, established
on the basis of a single ABPM, was not associated with more
pronounced cardiac involvement. In fact, we found no signiﬁ-
cant difference in left ventricular size and systolic function or
prevalence of cardiac hypertrophy between patients with and
without a normal fall in BP during night time.
Our study had some limitations. First, we did not include
diabetic patients. We aimed to make the study sample as uni-
form as possible, accordingly, we excluded diabetes as an
important risk factor for vasculopathy and hypertension. This
implies that our results are only applicable to non-diabetic
hypertensive patients.
Second, some factors could not be excluded from the study,
e.g. dyslipidemia and smoking. These were however insigniﬁ-
cant between the hypertensive and control groups. Hyperten-
sion duration is also among the strongly signiﬁcant factors
that were correlated with the patients’ cognitive ability. This
seems to be a logical relation; as the duration of hypertension
increases, its target organ effect on the brain increases. How-
ever, based on the multivariate analysis, the average morning
systolic blood pressure had a stronger impact on the MMSE
and MRI scores than the duration of hypertension.
Finally, the effect of treatment was not evaluated in our
study. This is a very important issue that needs a longitudinal
study with long term follow up to record the change in cogni-
tive function and MRI score, not to mention studying the dif-
ferent effects of variable drug combinations to achieve BP
control.
7. Conclusion
The study demonstrated a stronger correlation between the 24-
h ABPM data and the cognitive function of elderly hyperten-
sive patients, a relation which was not evident using ofﬁce
BP measurement.
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